These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

462 related items for PubMed ID: 17884266

  • 1. Cognitive functioning related to quality of life in schizophrenia.
    Matsui M, Sumiyoshi T, Arai H, Higuchi Y, Kurachi M.
    Prog Neuropsychopharmacol Biol Psychiatry; 2008 Jan 01; 32(1):280-7. PubMed ID: 17884266
    [Abstract] [Full Text] [Related]

  • 2. [Interest of a new instrument to assess cognition in schizophrenia: The Brief Assessment of Cognition in Schizophrenia (BACS)].
    Bralet MC, Navarre M, Eskenazi AM, Lucas-Ross M, Falissard B.
    Encephale; 2008 Dec 01; 34(6):557-62. PubMed ID: 19081451
    [Abstract] [Full Text] [Related]

  • 3. Neurocognitive function in clinically stable men with bipolar I disorder or schizophrenia and normal control subjects.
    Altshuler LL, Ventura J, van Gorp WG, Green MF, Theberge DC, Mintz J.
    Biol Psychiatry; 2004 Oct 15; 56(8):560-9. PubMed ID: 15476685
    [Abstract] [Full Text] [Related]

  • 4. Is quality of life associated with cognitive impairment in schizophrenia?
    Alptekin K, Akvardar Y, Kivircik Akdede BB, Dumlu K, Işik D, Pirinçci F, Yahssin S, Kitiş A.
    Prog Neuropsychopharmacol Biol Psychiatry; 2005 Feb 15; 29(2):239-44. PubMed ID: 15694230
    [Abstract] [Full Text] [Related]

  • 5. Relationships between cognitive deficits, symptoms and quality of life in schizophrenia.
    Savilla K, Kettler L, Galletly C.
    Aust N Z J Psychiatry; 2008 Jun 15; 42(6):496-504. PubMed ID: 18465376
    [Abstract] [Full Text] [Related]

  • 6. Neurocognitive, clinical and functional correlates of subjective quality of life in Asian outpatients with schizophrenia.
    Woon PS, Chia MY, Chan WY, Sim K.
    Prog Neuropsychopharmacol Biol Psychiatry; 2010 Apr 16; 34(3):463-8. PubMed ID: 20109511
    [Abstract] [Full Text] [Related]

  • 7. Quality of life in bipolar type I disorder and schizophrenia in remission: clinical and neurocognitive correlates.
    Brissos S, Dias VV, Carita AI, Martinez-Arán A.
    Psychiatry Res; 2008 Jul 15; 160(1):55-62. PubMed ID: 18485488
    [Abstract] [Full Text] [Related]

  • 8. Predictors of subjective and objective quality of life in outpatients with schizophrenia.
    Yamauchi K, Aki H, Tomotake M, Iga J, Numata S, Motoki I, Izaki Y, Tayoshi S, Kinouchi S, Sumitani S, Tayoshi S, Takikawa Y, Kaneda Y, Taniguchi T, Ishimoto Y, Ueno S, Ohmori T.
    Psychiatry Clin Neurosci; 2008 Aug 15; 62(4):404-11. PubMed ID: 18778437
    [Abstract] [Full Text] [Related]

  • 9. Posttraumatic stress disorder, cognitive function and quality of life in patients with schizophrenia.
    Fan X, Henderson DC, Nguyen DD, Cather C, Freudenreich O, Evins AE, Borba CP, Goff DC.
    Psychiatry Res; 2008 May 30; 159(1-2):140-6. PubMed ID: 18423611
    [Abstract] [Full Text] [Related]

  • 10. Substance abuse and cognitive functioning in schizophrenia.
    Addington J, Addington D.
    J Psychiatry Neurosci; 1997 Mar 30; 22(2):99-104. PubMed ID: 9074303
    [Abstract] [Full Text] [Related]

  • 11. Effects of switching to long-acting injectable risperidone from oral atypical antipsychotics on cognitive function in patients with schizophrenia.
    Kim SW, Shin IS, Kim JM, Lee SH, Lee YH, Yang SJ, Yoon JS.
    Hum Psychopharmacol; 2009 Oct 30; 24(7):565-73. PubMed ID: 19790174
    [Abstract] [Full Text] [Related]

  • 12. Relationship of psychopathological symptoms and cognitive function to subjective quality of life in patients with chronic schizophrenia.
    Tomida K, Takahashi N, Saito S, Maeno N, Iwamoto K, Yoshida K, Kimura H, Iidaka T, Ozaki N.
    Psychiatry Clin Neurosci; 2010 Feb 30; 64(1):62-9. PubMed ID: 19968832
    [Abstract] [Full Text] [Related]

  • 13. Effect of perospirone on P300 electrophysiological activity and social cognition in schizophrenia: a three-dimensional analysis with sloreta.
    Sumiyoshi T, Higuchi Y, Itoh T, Matsui M, Arai H, Suzuki M, Kurachi M, Sumiyoshi C, Kawasaki Y.
    Psychiatry Res; 2009 Jun 30; 172(3):180-3. PubMed ID: 19386475
    [Abstract] [Full Text] [Related]

  • 14. Subjective assessments of the quality of life, well-being and self-efficacy in patients with schizophrenia.
    Chino B, Nemoto T, Fujii C, Mizuno M.
    Psychiatry Clin Neurosci; 2009 Aug 30; 63(4):521-8. PubMed ID: 19531107
    [Abstract] [Full Text] [Related]

  • 15. Comparative study of neurocognitive function in euthymic bipolar patients and stabilized schizophrenic patients.
    Sánchez-Morla EM, Barabash A, Martínez-Vizcaíno V, Tabarés-Seisdedos R, Balanzá-Martínez V, Cabranes-Díaz JA, Baca-Baldomero E, Gómez JL.
    Psychiatry Res; 2009 Oct 30; 169(3):220-8. PubMed ID: 19758705
    [Abstract] [Full Text] [Related]

  • 16. Community dysfunction in schizophrenia: rate-limiting factors.
    Bozikas VP, Kosmidis MH, Kafantari A, Gamvrula K, Vasiliadou E, Petrikis P, Fokas K, Karavatos A.
    Prog Neuropsychopharmacol Biol Psychiatry; 2006 May 30; 30(3):463-70. PubMed ID: 16442195
    [Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19. Cognitive and psychomotor effects of risperidone in schizophrenia and schizoaffective disorder.
    Houthoofd SA, Morrens M, Sabbe BG.
    Clin Ther; 2008 Sep 30; 30(9):1565-89. PubMed ID: 18840365
    [Abstract] [Full Text] [Related]

  • 20. Quality of life and subjective well-being during treatment with antipsychotics in out-patients with schizophrenia.
    Wehmeier PM, Kluge M, Schneider E, Schacht A, Wagner T, Schreiber W.
    Prog Neuropsychopharmacol Biol Psychiatry; 2007 Apr 13; 31(3):703-12. PubMed ID: 17289237
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 24.